Advertisement

Evaluation of Iron Status in Patients of Solid Organ Malignancies: Study from a Cancer Research Centre

  • Deepak SundriyalEmail author
  • Priya P. Nayak
  • Lima Arya
  • Meenu Walia
  • Rajat Saha
Original Article

Abstract

Anemia associated with cancer is a major public health issue. The gravity of this problem is likely to be higher in India due to already existing malnutrition in the general population. Iron deficiency anemia (IDA) as a subset has not been evaluated in Indian population of cancer patients. This study was undertaken to evaluate iron status among newly diagnosed advanced-stage cancer patients with anemia at a cancer research institute in India. Sixty-four patients of anemia were identified who fulfilled the inclusion criteria. Iron status was noted. Absolute iron deficiency (AID) was identified in 8 (12.5%) patients. Functional iron deficiency (FID) was seen in 48 (75%) patients. Probable functional iron deficiency (PFID) was seen in 2 (3.1%) patients while no iron deficiency (NID) was seen in 6 (9.3%) patients. FID is seen in majority of advanced-stage solid organ cancer patients in India. Large sample studies are required to better define the exact prevalence of iron deficiency, chemotherapy-induced anemia, and anemia in cancer subtypes.

Keywords

Anemia in cancer Iron deficiency anemia Functional iron deficiency 

Notes

Author Contributions

DS, LA, and RS were involved in the data collection. PPN, MW, and DS wrote the manuscript. DS and LA reviewed the final manuscript.

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflicts of interest.

References

  1. 1.
    Caro JJ, Salas M, Ward A, Goss G (2001) Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 91:2214–2221CrossRefGoogle Scholar
  2. 2.
    Knight K, Wade S, Balducci L (2004) Prevalence and outcomes of anemia in cancer: a systemic review of the literature. Am J Med 116(Suppl7A):11S–26SCrossRefGoogle Scholar
  3. 3.
    Ludwig H, Van BS, Barrett-Lee P, Birgegard G, Bokemeyer C, Gascon P et al (2004) The European Cancer Anemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anemia in cancer patients. Eur J Cancer 40:2293–2306CrossRefGoogle Scholar
  4. 4.
    Tas F, Eralp Y, Basaran M, Sakar B, Alici S, Argon A, Bulutlar G, Camlica H, Aydiner A, Topuz E (2002) Anemia in oncology practice: relation to diseases and their therapies. Am J Clin Oncol 25(4):371–379CrossRefGoogle Scholar
  5. 5.
    Adamson J (2008) The anemia of inflammation/malignancy: mechanism and management. Hematology Am Soc Haematol Educ Program 2008:159–165CrossRefGoogle Scholar
  6. 6.
    Kuvibidila SR, Gauthier T, Rayford W (2004) Serum ferritin levels and transferring saturation in men with prostate cancer. J Natl Med Assoc 96:641–649PubMedPubMedCentralGoogle Scholar
  7. 7.
    Beale AL, Penney MD, Allison MC (2005) The prevalence of iron deficiency among patient presenting with colorectal cancer. Color Dis 7:398–402CrossRefGoogle Scholar
  8. 8.
    Xu H, Xu L, Page JH, Cannavale K, Sattayapiwat O, Rodriguez R, Chao C (2016) Incidence of anemia in patients diagnosed with solid tumors receiving chemotherapy, 2010-2013. Clin Epidemiol 8:61–71CrossRefGoogle Scholar
  9. 9.
    Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0 [Online]. 2017 Nov 27[cited 2017 Nov 27]; Available from: URL: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_5x7.pdf
  10. 10.
    National Comprehensive Cancer Network. NCCN practice guidelines in oncology; Cancer and Chemotherapy-Induced Anemia – V2.2018. Available at http://www.nccn.org/professionals/physician_gls/pdf/anemia.pdf
  11. 11.
    Zubrod CG, Scheiderman M, Frei E, Brindley C, Gold LG, Shnider B et al (1960) Cancer – appraisal of methods for the study of chemotherapy of cancer in man: thiophosphamide. J Chronic Dis 11:7–33CrossRefGoogle Scholar
  12. 12.
    National Cancer Institute Anemia Scale. Adapted from the Common Terminology Criteria for Adverse Events. Available at: http://evs.nci.nih.gov/ftp1/CTCAE/About.html
  13. 13.
    Naoum FA (2016) Iron deficiency in cancer patients. Rev Bras Hematol Hemoter 38:325–330CrossRefGoogle Scholar
  14. 14.
    Hashemi SM, Mashhadi MA, Mohammadi M, Ebrahimi M, Allahyari A (2017) Absolute and functional iron deficiency anemia among different tumors in cancer patients in south part of Iran, 2014. Int J Hematol Oncol Stem Cell Res 11:192–198PubMedPubMedCentralGoogle Scholar
  15. 15.
    Neoh K, Stanworth S, Pasricha SR, Bennett MI (2017) Estimating prevalence of functional iron deficiency anemia in advanced cancer. Support Care Cancer 25:1209–1214CrossRefGoogle Scholar
  16. 16.
    Kanuri G, Sawhney R, Varghese J, Britto M, Shet A (2016) Iron deficiency anemia coexists with cancer related anemia and adversely impacts quality of life. PLoS One 11:e0163817CrossRefGoogle Scholar
  17. 17.
    Hedenus M, Karlsson T, Ludwig H, Rzychon B, Felder M, Roubert B (2014) Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy. Med Oncol 31:302CrossRefGoogle Scholar
  18. 18.
    Gafter-Gvili A, Rozen-Zvi B, Vidal L, Leibovici L, Vansteenkiste J, Gafter U, Shpilberg O (2013) Intravenous iron supplementation for the treatment of chemotherapy-induced anemia: systematic review and meta-analysis of randomised controlled trials. Acta Oncol 52(1):18–29CrossRefGoogle Scholar

Copyright information

© Indian Association of Surgical Oncology 2019

Authors and Affiliations

  1. 1.All India Institute of Medical SciencesRishikeshIndia
  2. 2.IMS and Sum HospitalBhubaneshwarIndia
  3. 3.Max Superspeciality HospitalNew DelhiIndia

Personalised recommendations